HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Arndt Hartmann Selected Research
Arndt Hartmann Research Topics
Disease
321
Neoplasms (Cancer)
05/2024 - 03/2002
100
Carcinoma (Carcinomatosis)
03/2024 - 05/2002
86
Breast Neoplasms (Breast Cancer)
04/2024 - 01/2004
80
Urinary Bladder Neoplasms (Bladder Cancer)
01/2024 - 03/2002
54
Renal Cell Carcinoma (Grawitz Tumor)
12/2023 - 03/2003
30
Prostatic Neoplasms (Prostate Cancer)
05/2024 - 04/2005
30
Neoplasm Metastasis (Metastasis)
02/2024 - 09/2004
25
Colorectal Neoplasms (Colorectal Cancer)
01/2023 - 09/2004
20
Non-Muscle Invasive Bladder Neoplasms
02/2024 - 05/2012
19
Carcinogenesis
01/2019 - 11/2002
15
Colonic Neoplasms (Colon Cancer)
05/2023 - 09/2004
13
Microsatellite Instability
05/2024 - 02/2003
13
Inflammation (Inflammations)
10/2023 - 03/2010
12
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2023 - 01/2006
11
Squamous Cell Carcinoma of Head and Neck
01/2024 - 01/2006
11
Triple Negative Breast Neoplasms
01/2024 - 06/2017
11
Rectal Neoplasms (Rectal Cancer)
01/2023 - 02/2012
11
Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022 - 05/2007
10
Adenocarcinoma
04/2023 - 01/2008
10
Lymphatic Metastasis
02/2021 - 05/2008
9
Sarcoma (Soft Tissue Sarcoma)
02/2024 - 06/2014
8
Lung Neoplasms (Lung Cancer)
11/2023 - 05/2007
8
Margins of Excision
01/2022 - 06/2009
8
Disease Progression
11/2020 - 04/2010
7
Adenocarcinoma of Lung
07/2023 - 12/2014
7
Hypoxia (Hypoxemia)
01/2022 - 04/2009
7
Melanoma (Melanoma, Malignant)
01/2021 - 04/2005
7
Hepatocellular Carcinoma (Hepatoma)
01/2018 - 05/2005
6
Ulcerative Colitis
01/2024 - 09/2010
6
Ovarian Neoplasms (Ovarian Cancer)
01/2023 - 03/2007
6
Adenoma (Adenomas)
04/2016 - 04/2007
5
Necrosis
05/2023 - 04/2005
5
Leiomyomatosis
11/2020 - 01/2013
4
Kidney Neoplasms (Kidney Cancer)
12/2023 - 01/2013
4
COVID-19
01/2023 - 03/2021
4
Noninfiltrating Intraductal Carcinoma (DCIS)
10/2022 - 11/2007
Drug/Important Bio-Agent (IBA)
122
Proteins (Proteins, Gene)
FDA Link
03/2024 - 11/2002
68
Biomarkers (Surrogate Marker)
IBA
05/2024 - 01/2008
60
Messenger RNA (mRNA)
IBA
04/2023 - 10/2003
37
Paraffin
IBA
01/2023 - 08/2002
34
Phenobarbital (Luminal)
FDA Link
03/2024 - 01/2007
32
DNA (Deoxyribonucleic Acid)
IBA
01/2023 - 08/2002
31
Formaldehyde (Formol)
FDA Link
01/2023 - 04/2005
27
Hormones (Hormone)
IBA
04/2024 - 11/2008
27
RNA (Ribonucleic Acid)
IBA
02/2024 - 10/2003
24
Immune Checkpoint Inhibitors
IBA
05/2024 - 11/2016
15
Estrogen Receptors
IBA
01/2023 - 12/2008
15
MicroRNAs (MicroRNA)
IBA
11/2022 - 04/2010
14
B7-H1 Antigen
IBA
04/2024 - 01/2016
14
Transcription Factors (Transcription Factor)
IBA
02/2024 - 11/2008
14
Progesterone Receptors (Progesterone Receptor)
IBA
01/2023 - 11/2009
10
Cadherins (E-Cadherin)
IBA
01/2024 - 02/2009
10
Antibodies
IBA
05/2023 - 01/2006
9
Platinum
IBA
04/2022 - 03/2007
9
Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)
IBA
01/2021 - 08/2007
9
Codon (Codons)
IBA
01/2018 - 05/2002
8
Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)
IBA
01/2024 - 08/2006
8
Indicators and Reagents (Reagents)
IBA
11/2023 - 01/2004
8
Cisplatin (Platino)
FDA Link
Generic
04/2021 - 08/2010
8
Acids
IBA
11/2017 - 03/2002
7
ErbB Receptors (EGF Receptor)
IBA
04/2024 - 01/2006
7
Ligands
IBA
01/2024 - 02/2015
7
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
12/2023 - 02/2013
7
pembrolizumab
IBA
05/2023 - 01/2019
7
Estrogens (Estrogen)
FDA Link
01/2023 - 11/2008
7
HLA-G Antigens (HLA G)
IBA
11/2022 - 06/2015
7
Keratins (Keratin)
IBA
02/2022 - 03/2011
7
Androgen Receptors (Androgen Receptor)
IBA
06/2021 - 06/2017
6
Tyrosine Kinase Inhibitors
IBA
12/2023 - 06/2014
6
HLA Antigens (Human Leukocyte Antigens)
IBA
01/2022 - 04/2012
6
Fumarate Hydratase (Fumarase)
IBA
11/2020 - 01/2016
6
Protein Isoforms (Isoforms)
IBA
01/2020 - 04/2009
5
Immunoconjugates (Immunoconjugate)
IBA
04/2024 - 12/2021
5
Fluorouracil (Carac)
FDA Link
Generic
05/2023 - 05/2006
5
Programmed Cell Death 1 Receptor
IBA
01/2023 - 01/2016
5
trans-sodium crocetinate (crocetin)
IBA
10/2022 - 11/2021
5
Sucrose (Saccharose)
IBA
01/2018 - 08/2015
5
Carrier Proteins (Binding Protein)
IBA
08/2017 - 06/2011
5
WD repeat containing planar cell polarity effector
IBA
10/2015 - 04/2004
5
SERPIN-B5 (maspin)
IBA
05/2012 - 04/2005
5
Complementary DNA (cDNA)
IBA
06/2009 - 04/2004
4
Phosphotransferases (Kinase)
IBA
04/2024 - 01/2004
4
enfortumab vedotin
IBA
04/2024 - 01/2023
4
C-Reactive Protein
IBA
11/2023 - 11/2019
4
Lipids
IBA
10/2023 - 03/2010
4
Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)
FDA Link
07/2023 - 08/2009
4
Interferons
IBA
01/2023 - 01/2008
4
Antigens
IBA
11/2022 - 01/2018
Therapy/Procedure
113
Therapeutics
04/2024 - 12/2003
43
Drug Therapy (Chemotherapy)
01/2023 - 12/2003
33
Cystectomy
02/2024 - 11/2002
28
Immunotherapy
05/2024 - 04/2010
24
Neoadjuvant Therapy
01/2024 - 02/2011
13
Lasers (Laser)
01/2023 - 12/2002
13
Adjuvant Chemotherapy
08/2022 - 08/2010
12
Chemoradiotherapy
01/2023 - 02/2012
9
Radiotherapy
01/2023 - 12/2003
9
Prostatectomy (Retropubic Prostatectomy)
07/2015 - 11/2008
7
Aftercare (After-Treatment)
09/2022 - 04/2004
6
Transurethral Resection of Bladder
02/2024 - 07/2017